Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Elizabeth McFarland

Concepts (388)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
52
2026
3186
3.100
 Why?
HIV-1
28
2026
906
2.880
 Why?
Respiratory Syncytial Virus Vaccines
6
2022
39
2.210
 Why?
HIV Antibodies
14
2026
61
2.210
 Why?
Respiratory Syncytial Virus Infections
6
2022
139
2.010
 Why?
Respiratory Syncytial Virus, Human
6
2022
81
2.000
 Why?
Infectious Disease Transmission, Vertical
18
2025
194
1.980
 Why?
Anti-HIV Agents
15
2026
908
1.710
 Why?
Anti-Retroviral Agents
12
2023
251
1.630
 Why?
Viral Proteins
3
2020
350
1.480
 Why?
Antibodies, Neutralizing
10
2026
340
1.110
 Why?
Antibodies, Viral
8
2022
673
1.060
 Why?
Antibodies, Monoclonal
7
2026
1505
0.950
 Why?
Colonography, Computed Tomographic
3
2024
8
0.920
 Why?
Pregnancy Complications, Infectious
9
2026
438
0.870
 Why?
HIV Protease Inhibitors
3
2026
69
0.820
 Why?
AIDS Vaccines
8
2018
53
0.810
 Why?
Pre-Exposure Prophylaxis
1
2025
268
0.720
 Why?
Gene Deletion
2
2020
391
0.690
 Why?
Breast Feeding
4
2025
446
0.610
 Why?
Atazanavir Sulfate
2
2017
42
0.600
 Why?
Ritonavir
2
2017
75
0.580
 Why?
Infant, Newborn
24
2026
6435
0.560
 Why?
HIV Envelope Protein gp120
6
2017
55
0.550
 Why?
Vaccination
6
2020
1423
0.550
 Why?
Vaccines, Attenuated
6
2022
129
0.540
 Why?
Incidental Findings
1
2018
81
0.520
 Why?
Infant
33
2026
10060
0.510
 Why?
Radiation Dosage
1
2018
193
0.480
 Why?
Nelfinavir
1
2016
8
0.480
 Why?
Telemedicine
1
2025
956
0.470
 Why?
Lopinavir
1
2016
30
0.470
 Why?
Syncope
1
2016
56
0.470
 Why?
Patient Dropouts
1
2016
65
0.460
 Why?
Bradycardia
1
2016
61
0.460
 Why?
Lyme Disease
1
2016
58
0.450
 Why?
Health Resources
1
2016
130
0.440
 Why?
Infant, Newborn, Diseases
1
2016
115
0.420
 Why?
HIV
5
2014
251
0.390
 Why?
Humans
78
2026
145140
0.380
 Why?
Patient Compliance
2
2018
587
0.380
 Why?
Child
38
2026
22670
0.370
 Why?
Female
52
2026
78636
0.370
 Why?
Immunogenicity, Vaccine
4
2021
36
0.360
 Why?
Referral and Consultation
1
2018
862
0.340
 Why?
T-Lymphocytes, Cytotoxic
4
2005
177
0.330
 Why?
Male
43
2026
72664
0.330
 Why?
Virus Replication
4
2020
519
0.330
 Why?
CD4-Positive T-Lymphocytes
2
2017
1138
0.330
 Why?
Adolescent
28
2025
22479
0.320
 Why?
Viral Load
10
2026
525
0.310
 Why?
Lymphocyte Activation
5
2017
1131
0.300
 Why?
Young Adult
14
2026
14176
0.270
 Why?
DNA, Viral
3
2026
355
0.260
 Why?
HIV Seropositivity
2
2023
119
0.260
 Why?
Bone Density
2
2025
484
0.260
 Why?
Double-Blind Method
3
2020
2057
0.250
 Why?
RNA, Viral
8
2023
690
0.240
 Why?
Antibodies, Bacterial
2
2018
147
0.230
 Why?
Antiretroviral Therapy, Highly Active
6
2017
279
0.220
 Why?
Dyslipidemias
2
2017
184
0.220
 Why?
Prenatal Exposure Delayed Effects
2
2026
650
0.220
 Why?
Bone Development
1
2025
52
0.220
 Why?
Puberty
1
2026
136
0.220
 Why?
Immunoenzyme Techniques
1
2005
200
0.210
 Why?
Pregnancy
12
2026
7182
0.210
 Why?
Immunoglobulin G
3
2022
887
0.210
 Why?
Diverticulum
1
2024
15
0.200
 Why?
Viremia
3
2011
160
0.200
 Why?
Gene Products, gag
2
1994
38
0.200
 Why?
Mammography
1
2025
166
0.200
 Why?
Child, Preschool
21
2022
11835
0.190
 Why?
Squalene
3
2017
8
0.190
 Why?
Complementarity Determining Regions
1
2002
54
0.180
 Why?
Prospective Studies
5
2025
8035
0.180
 Why?
Drug Resistance, Viral
2
2016
124
0.180
 Why?
CD4 Lymphocyte Count
4
2017
280
0.180
 Why?
Growth Differentiation Factor 15
1
2021
41
0.170
 Why?
Half-Life
1
2021
153
0.170
 Why?
Feasibility Studies
1
2025
1109
0.170
 Why?
Immunization Schedule
2
2018
186
0.170
 Why?
Mitochondrial Diseases
1
2021
92
0.170
 Why?
Colorado
4
2025
4538
0.170
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
333
0.160
 Why?
Drug Therapy, Combination
4
2017
1043
0.160
 Why?
T-Lymphocytes
2
2009
1993
0.160
 Why?
RNA, Small Untranslated
1
2020
14
0.160
 Why?
Fibroblast Growth Factors
1
2021
188
0.160
 Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
15
0.160
 Why?
Pilot Projects
1
2025
1889
0.150
 Why?
Cytokines
2
2021
2048
0.150
 Why?
Hydrophobic and Hydrophilic Interactions
1
2020
192
0.150
 Why?
Point Mutation
1
2020
239
0.140
 Why?
Body Temperature
1
2020
227
0.140
 Why?
Immunocompromised Host
2
2000
202
0.140
 Why?
Haemophilus Vaccines
2
2018
29
0.140
 Why?
Insulin Resistance
3
2019
1244
0.140
 Why?
Immunologic Memory
2
2021
368
0.140
 Why?
Interleukin-12
1
1998
115
0.130
 Why?
Darunavir
1
2017
20
0.130
 Why?
Mycobacterium Infections, Nontuberculous
2
2012
339
0.130
 Why?
CD8-Positive T-Lymphocytes
2
2011
917
0.130
 Why?
Metabolic Syndrome
1
2021
360
0.130
 Why?
Dose-Response Relationship, Drug
1
2021
2026
0.130
 Why?
Therapeutic Equipoise
1
2017
2
0.130
 Why?
Interferon-gamma
5
2012
784
0.130
 Why?
Antibody Formation
1
2018
287
0.130
 Why?
Immunoglobulin A
2
2017
214
0.130
 Why?
Lymphopoiesis
1
2017
27
0.130
 Why?
Uganda
1
2017
89
0.120
 Why?
Receptors, CCR5
1
2017
60
0.120
 Why?
CD4-CD8 Ratio
1
2016
23
0.120
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
9
0.120
 Why?
High-Throughput Screening Assays
1
2018
175
0.120
 Why?
Adoption
1
2016
25
0.120
 Why?
Mothers
3
2017
764
0.120
 Why?
Adult
16
2026
40665
0.120
 Why?
Virus Latency
1
2016
90
0.120
 Why?
Cohort Studies
8
2025
5988
0.120
 Why?
Early Diagnosis
1
2016
251
0.110
 Why?
Chickenpox Vaccine
1
2015
75
0.110
 Why?
Continuity of Patient Care
1
2018
296
0.110
 Why?
Disease Susceptibility
1
2017
343
0.110
 Why?
Zimbabwe
2
2025
76
0.110
 Why?
Body Height
2
2017
201
0.110
 Why?
Gene Products, env
1
1994
7
0.110
 Why?
Chickenpox
1
2015
82
0.110
 Why?
Haemophilus influenzae type b
1
2014
12
0.110
 Why?
Bacterial Capsules
1
2014
33
0.110
 Why?
Antibody Affinity
1
2014
60
0.110
 Why?
Acquired Immunodeficiency Syndrome
2
2000
237
0.100
 Why?
Cote d'Ivoire
2
2025
9
0.100
 Why?
Parotitis
1
2014
6
0.100
 Why?
Vaccines, Synthetic
4
2005
137
0.100
 Why?
South Africa
2
2025
266
0.100
 Why?
Developing Countries
1
2016
316
0.100
 Why?
Intestines
1
2017
354
0.100
 Why?
Puberty, Delayed
1
2013
10
0.100
 Why?
Leukocytes, Mononuclear
4
2013
573
0.100
 Why?
Cytotoxicity, Immunologic
3
2002
224
0.100
 Why?
Vaccines
1
2018
388
0.100
 Why?
RNA-Directed DNA Polymerase
1
1993
35
0.100
 Why?
Mycobacterium chelonae
1
1993
8
0.100
 Why?
Injections, Subcutaneous
2
2026
170
0.100
 Why?
Patient Selection
1
2017
733
0.090
 Why?
Lipids
1
2017
706
0.090
 Why?
Lamivudine
3
2023
65
0.090
 Why?
Retrospective Studies
8
2023
17247
0.090
 Why?
Cell Movement
1
2017
959
0.090
 Why?
Colorectal Neoplasms
1
2020
864
0.090
 Why?
Breast Neoplasms
1
2025
2380
0.090
 Why?
Mitochondria
2
2021
992
0.090
 Why?
STAT1 Transcription Factor
1
2012
66
0.090
 Why?
Cardiovascular Diseases
2
2016
2183
0.090
 Why?
Child Development
1
2017
483
0.090
 Why?
Body Weight
2
2017
969
0.090
 Why?
Pediatric Obesity
1
2019
637
0.090
 Why?
Body Fat Distribution
1
2011
46
0.090
 Why?
Clinical Trials as Topic
1
2017
1058
0.090
 Why?
Polysorbates
3
2017
42
0.090
 Why?
Mycobacterium avium Complex
1
2012
87
0.080
 Why?
Epitopes
2
2022
473
0.080
 Why?
Cost-Benefit Analysis
2
2025
640
0.080
 Why?
Research Design
1
2017
1132
0.080
 Why?
United States
9
2023
16065
0.080
 Why?
Biomedical Research
1
2017
717
0.080
 Why?
Interleukin-2
2
2003
440
0.080
 Why?
Respiratory Tract Infections
1
2014
394
0.070
 Why?
Freezing
1
2009
83
0.070
 Why?
Exercise
1
2021
2191
0.070
 Why?
Absorptiometry, Photon
2
2025
276
0.070
 Why?
Blood
1
2009
107
0.070
 Why?
Phenotype
1
2017
3138
0.070
 Why?
Algorithms
1
2016
1845
0.070
 Why?
Age Factors
4
2019
3338
0.070
 Why?
T-Lymphocyte Subsets
2
2002
417
0.070
 Why?
Staff Development
1
2009
63
0.070
 Why?
Lymphocyte Subsets
2
2009
77
0.070
 Why?
Enzyme-Linked Immunosorbent Assay
2
2021
847
0.070
 Why?
Biomarkers
4
2021
4282
0.070
 Why?
Longitudinal Studies
3
2025
2949
0.070
 Why?
Faculty
1
2009
147
0.070
 Why?
Enterovirus A, Human
1
2007
13
0.070
 Why?
Specimen Handling
1
2009
182
0.070
 Why?
Withholding Treatment
1
2008
80
0.060
 Why?
Adipose Tissue
1
2011
644
0.060
 Why?
Central Nervous System Viral Diseases
1
2007
78
0.060
 Why?
Polymerase Chain Reaction
4
2011
1039
0.060
 Why?
Flow Cytometry
3
2009
1159
0.060
 Why?
Academic Medical Centers
1
2009
552
0.060
 Why?
Monte Carlo Method
1
2026
147
0.060
 Why?
False Negative Reactions
1
2025
61
0.050
 Why?
Cell Line
3
2012
2821
0.050
 Why?
Enterovirus Infections
1
2007
173
0.050
 Why?
Isoantigens
1
1984
17
0.050
 Why?
C-Reactive Protein
2
2021
422
0.050
 Why?
Medical Audit
1
2025
77
0.050
 Why?
Immunity, Cellular
1
2006
273
0.050
 Why?
Linear Models
2
2020
844
0.050
 Why?
Disease Outbreaks
1
2007
419
0.050
 Why?
Follow-Up Studies
3
2021
5411
0.050
 Why?
Confusion
1
2024
30
0.050
 Why?
Sequence Analysis, DNA
2
2007
776
0.050
 Why?
Comorbidity
2
2021
1657
0.050
 Why?
Thymus Gland
1
1984
311
0.050
 Why?
Tablets
1
2023
41
0.050
 Why?
Constriction, Pathologic
1
2024
248
0.050
 Why?
Regression Analysis
2
2021
998
0.050
 Why?
Respiratory Syncytial Viruses
1
2022
58
0.050
 Why?
Genes, T-Cell Receptor beta
1
2002
23
0.050
 Why?
Risk Factors
4
2021
10857
0.050
 Why?
Immunophenotyping
2
1994
318
0.050
 Why?
Zidovudine
2
2015
77
0.050
 Why?
Clone Cells
1
2002
263
0.040
 Why?
Dose-Response Relationship, Immunologic
1
2001
76
0.040
 Why?
Cough
1
2022
123
0.040
 Why?
Emtricitabine
1
2023
209
0.040
 Why?
Triazoles
1
2023
187
0.040
 Why?
Vaccines, Subunit
1
2001
53
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2021
50
0.040
 Why?
Pyridones
1
2023
209
0.040
 Why?
Ganciclovir
1
2000
53
0.040
 Why?
Tenofovir
1
2023
300
0.040
 Why?
Public Health Surveillance
1
2021
83
0.040
 Why?
Lung
1
2014
4101
0.040
 Why?
Computer Simulation
1
2005
1002
0.040
 Why?
Africa
1
2020
118
0.040
 Why?
Adjuvants, Immunologic
2
2017
243
0.040
 Why?
Diagnostic Tests, Routine
1
2021
107
0.040
 Why?
Sex Factors
2
2019
2099
0.040
 Why?
Symptom Assessment
1
2021
136
0.040
 Why?
HIV Seronegativity
1
2019
29
0.040
 Why?
Cross-Sectional Studies
3
2021
5886
0.040
 Why?
HLA-D Antigens
1
1999
30
0.040
 Why?
Risk
1
2021
916
0.040
 Why?
Case-Control Studies
2
2019
3616
0.040
 Why?
Cytomegalovirus Infections
1
2000
206
0.040
 Why?
Lymphocyte Culture Test, Mixed
1
1998
49
0.040
 Why?
Cytotoxicity Tests, Immunologic
1
1998
38
0.040
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
28
0.030
 Why?
Vaccines, Combined
1
2018
49
0.030
 Why?
Prevalence
2
2016
2855
0.030
 Why?
Cholesterol, HDL
1
2019
201
0.030
 Why?
Amino Acid Sequence
1
2002
2127
0.030
 Why?
Hospitals
1
2023
732
0.030
 Why?
Poliovirus Vaccine, Inactivated
1
2018
27
0.030
 Why?
Odds Ratio
1
2021
1082
0.030
 Why?
Hepatitis B Vaccines
1
2018
43
0.030
 Why?
Mutation
3
2018
4071
0.030
 Why?
Drug Resistance, Microbial
2
2000
64
0.030
 Why?
Molecular Sequence Data
1
2002
2881
0.030
 Why?
Colon
1
2020
308
0.030
 Why?
Nutrition Surveys
1
2019
279
0.030
 Why?
Case Management
1
2018
68
0.030
 Why?
Antigens, Viral
1
1998
182
0.030
 Why?
Cholesterol, LDL
1
2019
360
0.030
 Why?
Cholesterol
1
2019
406
0.030
 Why?
Epitopes, T-Lymphocyte
1
1998
174
0.030
 Why?
Treatment Adherence and Compliance
1
2017
27
0.030
 Why?
Triglycerides
1
2019
520
0.030
 Why?
Immune Tolerance
1
1999
385
0.030
 Why?
Disease Management
1
2021
651
0.030
 Why?
Reproducibility of Results
1
2005
3410
0.030
 Why?
Cell Division
1
1998
753
0.030
 Why?
Lymphocyte Count
2
2009
163
0.030
 Why?
Uncertainty
1
2017
145
0.030
 Why?
Treatment Failure
1
2017
360
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Multicenter Studies as Topic
1
2017
410
0.030
 Why?
Seroepidemiologic Studies
1
2015
171
0.030
 Why?
Patient Outcome Assessment
1
2016
130
0.030
 Why?
Maternal Exposure
1
2017
188
0.030
 Why?
Genes, pol
1
1994
7
0.030
 Why?
Malnutrition
1
2016
86
0.030
 Why?
Antiviral Agents
1
2000
767
0.030
 Why?
Vaccines, Conjugate
1
2014
59
0.030
 Why?
Counseling
1
2018
400
0.030
 Why?
Time-to-Treatment
1
2017
250
0.030
 Why?
Coinfection
1
2016
143
0.030
 Why?
Neutropenia
1
2015
154
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1742
0.030
 Why?
Treatment Outcome
2
2021
11741
0.030
 Why?
Cells, Cultured
2
2008
4142
0.030
 Why?
Global Health
1
2017
403
0.020
 Why?
Maternal-Fetal Exchange
1
2014
170
0.020
 Why?
Anemia
1
2015
190
0.020
 Why?
Electron Transport Complex IV
1
2013
61
0.020
 Why?
Sexual and Gender Minorities
1
2018
259
0.020
 Why?
Electron Transport Complex I
1
2013
42
0.020
 Why?
Thrombocytopenia
1
2015
204
0.020
 Why?
Tuberculosis, Cutaneous
1
1993
2
0.020
 Why?
HIV Reverse Transcriptase
1
1993
31
0.020
 Why?
CD8 Antigens
1
1993
70
0.020
 Why?
Radiography, Thoracic
1
2014
172
0.020
 Why?
Severity of Illness Index
1
2021
2928
0.020
 Why?
Medication Adherence
1
2017
540
0.020
 Why?
CD3 Complex
1
1993
112
0.020
 Why?
Drug Administration Schedule
2
2008
781
0.020
 Why?
Lymphocytes
1
1994
376
0.020
 Why?
Blood Pressure
1
2019
1778
0.020
 Why?
Oxidative Phosphorylation
1
2013
209
0.020
 Why?
DNA, Mitochondrial
1
2013
211
0.020
 Why?
P-Selectin
1
2011
29
0.020
 Why?
Tuberculosis, Pulmonary
1
1993
127
0.020
 Why?
E-Selectin
1
2011
61
0.020
 Why?
Heteroduplex Analysis
1
2011
1
0.020
 Why?
Pandemics
1
2020
1703
0.020
 Why?
Chemokine CCL2
1
2011
112
0.020
 Why?
Antigens, CD
1
1994
558
0.020
 Why?
Blood Transfusion
1
1994
407
0.020
 Why?
Cell Proliferation
2
2009
2504
0.020
 Why?
Hyperlipidemias
1
2011
120
0.020
 Why?
Nontuberculous Mycobacteria
1
1993
189
0.020
 Why?
Interferon-alpha
1
2012
193
0.020
 Why?
Protein Multimerization
1
2012
204
0.020
 Why?
Cell Adhesion Molecules
1
2011
181
0.020
 Why?
Fibrinogen
1
2011
180
0.020
 Why?
Hospitalization
1
2021
2458
0.020
 Why?
Cross Infection
1
1993
260
0.020
 Why?
Infant, Premature
1
1994
619
0.020
 Why?
Healthcare Disparities
1
2017
731
0.020
 Why?
Diagnosis, Differential
1
2014
1506
0.020
 Why?
Pokeweed Mitogens
1
2009
6
0.020
 Why?
Human Experimentation
1
2009
12
0.020
 Why?
L-Selectin
1
2009
27
0.020
 Why?
Tetanus
1
2009
26
0.020
 Why?
Leukocyte Common Antigens
1
2009
87
0.020
 Why?
Candida
1
2009
45
0.020
 Why?
Multivariate Analysis
1
2011
1546
0.020
 Why?
Obesity
1
2021
3097
0.020
 Why?
Meningitis, Aseptic
1
2007
13
0.020
 Why?
Virus Cultivation
1
2007
31
0.020
 Why?
Phosphorylation
1
2012
1706
0.020
 Why?
Interleukin-6
1
2011
775
0.020
 Why?
Data Interpretation, Statistical
1
2009
368
0.020
 Why?
Cerebrospinal Fluid
1
2007
88
0.020
 Why?
Paralysis
1
2007
69
0.020
 Why?
Multiple Organ Failure
1
2007
120
0.020
 Why?
Kinetics
1
2010
1567
0.020
 Why?
B-Lymphocytes
1
2012
866
0.020
 Why?
Pregnancy Outcome
1
2010
500
0.010
 Why?
Genotype
1
2011
1844
0.010
 Why?
Respiratory System
1
2007
150
0.010
 Why?
Immunoglobulin A, Secretory
1
2005
8
0.010
 Why?
Cell Survival
1
2009
1100
0.010
 Why?
Phosphates
1
1987
177
0.010
 Why?
Muscles
1
1987
330
0.010
 Why?
Encephalitis
1
2007
142
0.010
 Why?
Gastrointestinal Tract
1
2007
204
0.010
 Why?
Mucous Membrane
1
2005
128
0.010
 Why?
Chemistry, Physical
1
1984
37
0.010
 Why?
Antigen-Antibody Reactions
1
1984
49
0.010
 Why?
Chemical Phenomena
1
1984
77
0.010
 Why?
DNA-Binding Proteins
1
2012
1479
0.010
 Why?
Myasthenia Gravis
1
1984
24
0.010
 Why?
Immunologic Deficiency Syndromes
1
1984
65
0.010
 Why?
Tissue Distribution
1
1984
335
0.010
 Why?
Saliva
1
2005
245
0.010
 Why?
Epithelium
1
1984
310
0.010
 Why?
Tomography, X-Ray Computed
1
2014
2767
0.010
 Why?
Blood Glucose
1
2013
2335
0.010
 Why?
Aging
2
2003
1962
0.010
 Why?
Body Mass Index
1
2011
2437
0.010
 Why?
Infusions, Intravenous
1
2003
428
0.010
 Why?
Middle Aged
2
2020
36126
0.010
 Why?
Reference Values
1
2003
798
0.010
 Why?
Anti-Bacterial Agents
1
1993
1922
0.010
 Why?
Mice, Inbred BALB C
1
1984
1261
0.010
 Why?
Suspensions
1
2000
28
0.010
 Why?
Capsules
1
2000
42
0.010
 Why?
Urban Population
1
2003
492
0.010
 Why?
Drug Tolerance
1
2000
99
0.010
 Why?
Cytomegalovirus
1
2000
168
0.010
 Why?
Signal Transduction
1
2012
5208
0.010
 Why?
Epithelial Cells
1
1984
1127
0.010
 Why?
Immunization
1
2000
375
0.010
 Why?
Administration, Oral
1
2000
862
0.010
 Why?
Time Factors
1
2008
7107
0.010
 Why?
Recombinant Proteins
1
2000
1368
0.010
 Why?
Macrophages
1
1984
1500
0.010
 Why?
Tail
1
1987
28
0.000
 Why?
Phosphocreatine
1
1987
44
0.000
 Why?
Mice
1
1984
18303
0.000
 Why?
Salamandridae
1
1987
33
0.000
 Why?
Animals
2
1987
37952
0.000
 Why?
Adenosine Triphosphate
1
1987
499
0.000
 Why?
Aged
1
1984
26096
0.000
 Why?
Magnetic Resonance Spectroscopy
1
1987
627
0.000
 Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (388) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)